Jennifer A. Schreiber

First-in-human phase 1 study of filanesib (ARRY-520), a kinesin spindle protein inhibitor, in patients with advanced solid tumors

Patricia LoRusso, Priscila Gonçalves, Lindsay Casetta et al. · Investigational New Drugs · 2015 · 46 citations

Tumor Biology, Medicine, Pathology +8

Abstract A252: A phase 1 study of ARRY-382, an oral inhibitor of colony-stimulating factor-1 receptor (CSF1R), in patients with advanced or metastatic cancers.

Johanna C. Bendell, Anthony W. Tolcher, Suzanne F. Jones et al. · Molecular Cancer Therapeutics · 2013 · 29 citations

Chemoprevention Strategy, Immunology, Pathology +21

The ongoing cognitive processing of exclusionary social events: Evidence from event-related potentials

Jason R. Themanson, Jennifer A. Schreiber, Amanda D. Larsen et al. · Social Neuroscience · 2014 · 22 citations

Neuropsychology, Exclusionary Social Events, Social Psychology +28

Uroflowmetry with pelvic floor electromyography: inter-rater agreement on diagnosis of pediatric non-neurogenic voiding disorders

Mark A. Faasse, Israel Nosnik, Dawn Diaz-Saldano et al. · Journal of Pediatric Urology · 2015 · 16 citations

Urology, Voiding Dysfunction, Pelvic Floor Disorders +9

Definition of Reliable, Objective Criteria by Abdominal Radiography to Identify Occult Constipation in Children with Lower Urinary Tract Symptoms

Andrew Marks, Evalynn Vasquez, Susan Moylan et al. · The Journal of Urology · 2012 · 15 citations